However, rituximab and BTK inhibitor treatment were correlated significantly with a negative vaccination response, whereas younger age and chronic myeloid leukemia (CML) disease were associated with positive response. The gene discussed is BTK; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.